HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ting Yu Selected Research

Stathmin

3/2019Introduction of exogenous wild‑type p53 mediates the regulation of oncoprotein 18/stathmin signaling via nuclear factor‑κB in non‑small cell lung cancer NCI‑H1299 cells.
1/2019In vitro neutralization of autocrine IL‑10 affects Op18/stathmin signaling in non‑small cell lung cancer cells.
1/2018RNAi targeting STMN alleviates the resistance to taxol and collectively contributes to down regulate the malignancy of NSCLC cells in vitro and in vivo.
7/2017The Cdc2/Cdk1 inhibitor, purvalanol A, enhances the cytotoxic effects of taxol through Op18/stathmin in non-small cell lung cancer cells in vitro.
4/2017Vinblastine differs from Taxol as it inhibits the malignant phenotypes of NSCLC cells by increasing the phosphorylation of Op18/stathmin.
12/2016Silencing Op18/stathmin by RNA Interference Promotes the Sensitivity of Nasopharyngeal Carcinoma Cells to Taxol and High-Grade Differentiation of Xenografted Tumours in Nude Mice.
3/2016Regulation of Oncoprotein 18/Stathmin Signaling by ERK Concerns the Resistance to Taxol in Nonsmall Cell Lung Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ting Yu Research Topics

Disease

84Neoplasms (Cancer)
10/2022 - 03/2005
20Neoplasm Metastasis (Metastasis)
05/2022 - 11/2005
17Infections
11/2021 - 10/2004
15Inflammation (Inflammations)
08/2022 - 01/2014
12Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 11/2005
11Obesity
01/2022 - 09/2007
11Breast Neoplasms (Breast Cancer)
01/2021 - 09/2007
8Colitis
04/2022 - 09/2015
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 03/2016
7Glioma (Gliomas)
01/2022 - 10/2012
7Carcinogenesis
01/2019 - 10/2004
6Parkinson Disease (Parkinson's Disease)
09/2022 - 12/2019
6Pain (Aches)
07/2022 - 07/2015
6Body Weight (Weight, Body)
07/2022 - 07/2008
6Colonic Neoplasms (Colon Cancer)
05/2022 - 01/2018
6COVID-19
11/2021 - 01/2020
6Hepatocellular Carcinoma (Hepatoma)
10/2021 - 04/2013
6Periodontitis
01/2021 - 10/2016
5Melanoma (Melanoma, Malignant)
09/2022 - 12/2017
5Lymphatic Metastasis
05/2022 - 11/2005
5Heart Failure
04/2022 - 01/2021
5Neurodegenerative Diseases (Neurodegenerative Disease)
09/2021 - 11/2012
5Lung Neoplasms (Lung Cancer)
10/2020 - 01/2018
4Stomach Neoplasms (Stomach Cancer)
05/2022 - 12/2017
4Hypertension (High Blood Pressure)
04/2022 - 11/2016
4Ulcerative Colitis
04/2022 - 01/2019
4Peripheral Nervous System Diseases (PNS Diseases)
03/2020 - 08/2014
4Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
03/2019 - 09/2015
4Prostatic Neoplasms (Prostate Cancer)
01/2016 - 08/2007
3Fibrosis (Cirrhosis)
12/2022 - 09/2010
3Tuberculosis (Tuberculoses)
12/2022 - 01/2015
3Shock
08/2022 - 07/2002
3Disease Resistance
11/2021 - 11/2018
3Carcinoma (Carcinomatosis)
01/2021 - 03/2016
3Diarrhea
01/2021 - 01/2017
3Constipation
12/2020 - 01/2017
3Circulating Neoplastic Cells
01/2019 - 01/2014
3Acute Lung Injury
03/2018 - 01/2018
3Mycoses (Diseases, Fungus)
02/2018 - 09/2014
3Abdominal Pain (Pain, Abdominal)
01/2017 - 01/2015
3Wounds and Injuries (Trauma)
06/2013 - 03/2007
3Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
04/2013 - 07/2012
3Ventricular Fibrillation
12/2002 - 07/2002
2Diabetes Mellitus
12/2022 - 10/2007

Drug/Important Bio-Agent (IBA)

27Proteins (Proteins, Gene)FDA Link
09/2022 - 03/2006
17Pharmaceutical PreparationsIBA
08/2022 - 04/2014
14Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2014
11CytokinesIBA
08/2022 - 01/2014
10Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 09/2012
8Messenger RNA (mRNA)IBA
05/2022 - 10/2007
8Biological ProductsIBA
04/2022 - 07/2011
8LipidsIBA
06/2020 - 07/2009
7Glucose (Dextrose)FDA LinkGeneric
01/2022 - 07/2009
7Peptides (Polypeptides)IBA
01/2022 - 06/2012
7StathminIBA
03/2019 - 03/2016
6MicroRNAs (MicroRNA)IBA
04/2022 - 01/2018
6AntigensIBA
10/2016 - 08/2007
5sodium sulfate (sodium bisulfate)FDA LinkGeneric
04/2022 - 01/2019
5Dextrans (Dextran)FDA Link
04/2022 - 01/2019
5Folic Acid (Vitamin M)FDA LinkGeneric
11/2021 - 03/2005
5Small Interfering RNA (siRNA)IBA
01/2021 - 01/2016
5Long Noncoding RNAIBA
01/2021 - 12/2017
5Antiviral Agents (Antivirals)IBA
11/2020 - 03/2011
5MicellesIBA
01/2020 - 01/2016
5Phosphotransferases (Kinase)IBA
12/2018 - 09/2015
5VaccinesIBA
11/2018 - 08/2007
4Circular RNAIBA
12/2021 - 02/2018
4AntioxidantsIBA
11/2021 - 01/2013
4Immune Checkpoint InhibitorsIBA
11/2021 - 12/2019
4CalciumIBA
10/2021 - 12/2008
4Therapeutic UsesIBA
10/2021 - 01/2018
4methoxy poly(ethylene glycol-co-epsilon-caprolactone)IBA
10/2020 - 01/2017
3Streptozocin (Streptozotocin)FDA Link
12/2022 - 10/2007
3BilirubinIBA
07/2022 - 04/2009
3Cadherins (E-Cadherin)IBA
05/2022 - 04/2018
3Caspase 3 (Caspase-3)IBA
01/2022 - 01/2018
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 01/2017
3Caspase 9IBA
01/2022 - 01/2018
3Indicators and Reagents (Reagents)IBA
08/2021 - 01/2016
3RNA (Ribonucleic Acid)IBA
08/2021 - 01/2019
3SaltsIBA
04/2021 - 01/2020
3DNA (Deoxyribonucleic Acid)IBA
12/2020 - 02/2016
3Fibrin Tissue Adhesive (Fibrin Sealant)IBA
09/2020 - 01/2018
3EnzymesIBA
01/2020 - 01/2014
3Interleukin-6 (Interleukin 6)IBA
03/2019 - 01/2014
3salicylhydroxamic acid (SHAM)IBA
01/2019 - 01/2017
3Cell Adhesion MoleculesIBA
01/2019 - 03/2014
3SolutionsIBA
09/2018 - 09/2017
3methoxy poly(ethylene glycol)-poly(lactide)IBA
01/2018 - 01/2016
3Interleukin-10 (Interleukin 10)IBA
01/2018 - 04/2014
3Advanced Glycation End ProductsIBA
01/2017 - 04/2015

Therapy/Procedure

47Therapeutics
12/2022 - 03/2005
14Drug Therapy (Chemotherapy)
01/2022 - 02/2016
8Immunotherapy
05/2022 - 03/2006
5Ligation
01/2021 - 10/2016
4Chemoprevention
01/2019 - 03/2005
3Oral Administration
07/2022 - 12/2018
3Chinese Traditional Medicine (Traditional Chinese Medicine)
07/2022 - 10/2020
3Radiotherapy
01/2021 - 01/2016
3Aftercare (After-Treatment)
10/2020 - 08/2019